Janus Living, Inc. (JAN)vsPrudential Financial Inc 4.125% Junior Subordinated Notes (PFH)
JAN
Janus Living, Inc.
$30.92
+0.36%
REAL ESTATE · Cap: $9.59B
PFH
Prudential Financial Inc 4.125% Junior Subordinated Notes
$15.15
+0.43%
REAL ESTATE · Cap: $45.49B
Smart Verdict
WallStSmart Research — data-driven comparison
JAN leads profitability with a 1.8% profit margin vs 0.0%. JAN earns a higher WallStSmart Score of 35/100 (F).
JAN
Avoid35
out of 100
Grade: F
PFH
Avoid25
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 45.4% year-over-year
Reasonable price relative to book value
Generating 2.3B in free cash flow
Areas to Watch
0.0% earnings growth
Distress zone — elevated risk
1.8% margin — thin
ROE of -0.1% — below average capital efficiency
0.0% revenue growth
0.0% earnings growth
0.0% margin — thin
Operating margin of 0.0%
Comparative Analysis Report
WallStSmart ResearchBull Case : JAN
The strongest argument for JAN centers on Revenue Growth, Price/Book. Revenue growth of 45.4% demonstrates continued momentum.
Bull Case : PFH
The strongest argument for PFH centers on Free Cash Flow.
Bear Case : JAN
The primary concerns for JAN are EPS Growth, Altman Z-Score, Profit Margin. Thin 1.8% margins leave little buffer for downturns.
Bear Case : PFH
The primary concerns for PFH are Revenue Growth, EPS Growth, Profit Margin.
Key Dynamics to Monitor
JAN profiles as a hypergrowth stock while PFH is a value play — different risk/reward profiles.
JAN is growing revenue faster at 45.4% — sustainability is the question.
PFH generates stronger free cash flow (2.3B), providing more financial flexibility.
Monitor REIT - RESIDENTIAL industry trends, competitive dynamics, and regulatory changes.
Bottom Line
JAN scores higher overall (35/100 vs 25/100) and 45.4% revenue growth. Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Janus Living, Inc.
REAL ESTATE · REIT - RESIDENTIAL · USA
JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for pain management. The company is headquartered in Las Vegas, Nevada.
Prudential Financial Inc 4.125% Junior Subordinated Notes
REAL ESTATE · REIT - RESIDENTIAL · USA
Corporation backed by corporate assets
Visit Website →Compare with Other REIT - RESIDENTIAL Stocks
Want to dig deeper into these stocks?